<DOC>
	<DOCNO>NCT00501072</DOCNO>
	<brief_summary>To investigate effectiveness safety Real Time Continuous Glucose Monitoring System ( RT-CGMS population patient type 1 diabetes mellitus treat insulin implanted pump .</brief_summary>
	<brief_title>Safety Efficacy RT-CGMS Patients With Type 1 Diabetes Mellitus Treated With Implantable Pump</brief_title>
	<detailed_description>Background : Strict glycaemic control reduce risk complication improve quality life patient type 1 diabetes mellitus . Real Time Continuous Glucose Monitoring System ( RT-CGMS ) novel system provide patient health care professional real time information blood glucose level without need multiple invasive measurement . Furthermore , continuous monitor possible identify trend glycaemic profile . Its effectiveness safety never test population patient type 1 diabetes mellitus treat insulin implanted pump . Objective : To investigate effectiveness safety RT-CGMS patient treat intraperitoneal continuous insulin infusion ( CIPII ) . Study design : Open label , randomize cross-over , single-center control trial . Study population : Patients CIPII . Intervention : There 3 study phase . In Baseline phase , patient RT-CGMS blind information blood glucose value measure store RT-CGMS available care-givers , investigator patient study period . Randomization determine sequence blind unblinded RT-CGMS 2nd 3rd phase . When RT-CGMS blind , system alert whenever glucose level fall rise preset value . Sensor value intend use directly make therapy adjustment . Whenever value preset value , blood glucose level measure use blood glucose meter therapy adjustment base value do accord protocol . Study endpoint : Primary : Percentage time spend euglycaemia . Secondary : percentage time spend hypoglycaemia hyperglycaemia , incidence severity hypoglycaemia ( measure SMBG ) , incidence adverse effect , number measurement blood glucose ( SMBG ) perform , number adjustment insulin therapy , patient satisfaction , agreement pair SMBG RT-CGMS measurement .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<criteria>Patients CIPII treat Isala Clinics , Zwolle , The Netherlands Age &gt; 18 year Uncontrolled diabetes mellitus type 1 Failure obtain informed consent Any condition prevention proper handle device , instance hearing impairment visual impairment Known allergy sensor ( part ) Currently pregnant try conceive</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>hyperglycemia</keyword>
	<keyword>hypoglycemia</keyword>
	<keyword>glucose variability</keyword>
	<keyword>insulin infusion system ; implantable insulin pump</keyword>
	<keyword>continuous glucose monitoring</keyword>
</DOC>